Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
about
The epigenetic landscape of acute myeloid leukemiaAcute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemiaRegulators associated with clinical outcomes revealed by DNA methylation data in breast cancer.DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia.Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes.Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patientsAnalysis of PTEN methylation patterns in soft tissue sarcomas by MassARRAY spectrometry.An optimized algorithm for detecting and annotating regional differential methylation.Quantitative survey of multiple CpGs from 5 genes identifies CpG methylation panel discriminating between high- and low-grade cervical intraepithelial neoplasiaIdentification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma.Validation of DNA methylation to predict outcome in acute myeloid leukemia by use of xMELPAllelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AMLEpigenetic Aging Signatures Are Coherently Modified in CancerHypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemiaValue of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid LeukemiaSpecific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies.Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML PatientsQuantitative analyses of DAPK1 methylation in AML and MDSMultiple roles of COUP-TFII in cancer initiation and progressionCell of origin determines clinically relevant subtypes of MLL-rearranged AMLOpportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.The Impact of DNA Methylation in Hematopoietic Malignancies.Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.Acute myeloid leukaemia: optimal management and recent developments.A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaDevelopment of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes.Induction of Chromosomal Instability via Telomere Dysfunction and Epigenetic Alterations in Myeloid NeoplasiaClinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission.The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation.Vorinostat in acute myeloid leukemia and myelodysplastic syndromes.Gene expression profiling in MDS and AML: potential and future avenues.Molecular diagnosis of leukemia.Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.
P2860
Q21284742-8B5FC604-5603-4BA4-8D09-BF0499CB2209Q27851694-C233D957-4CE0-4DD2-B911-8075797F2A7BQ28253465-4E189B67-581F-40E2-B1DF-E2D50F0A1D97Q30956005-275897AA-6FA5-46A4-9E6D-BB2E6FF45990Q33680945-0074DF93-31C1-4ABD-9614-F0A82B54EA8DQ33908446-31BAD780-E2D5-44DA-8166-F1391E432AFAQ34183388-1E7B35F8-6BF0-4786-9C8A-BD4759FA4823Q34318280-53FDB002-F4E3-4C45-9167-0F9057577922Q34426853-9CD9CD31-3341-4154-BEF9-5A41DE0E625CQ34729972-39E6F876-A811-48EB-935E-F3B7006A3675Q34756602-6D3D7797-D6FD-490A-9BEA-918C96CC14E5Q35101902-C6183AF9-FD95-46A0-B996-87E69F7B2E15Q35178079-A1B61E91-A409-428B-B2EA-1130DA21DF31Q35259528-AD6B9C15-8080-46D1-9522-B1346E787C0BQ35651714-F7018E29-FA6D-4688-BE96-2B9772552180Q35674189-129E4563-DDD1-46C2-B839-EE8938A887DDQ35816855-5878143D-6A9D-4FD6-BD0E-38FECD6BC31EQ36161529-E6DFDBD4-775E-4653-96BF-F902B68D9BF0Q36179524-FA3F4638-4FAA-4F2E-ACC2-F6C666BF83DFQ36216230-5A11072C-5211-46A6-A2E0-EFD8A11DF940Q36254052-7E6C1376-872F-41AE-96B8-A76FB8E46829Q36296317-63C9A24C-5113-4771-982E-3F7547E7BB06Q36312989-66698F99-3C4E-4311-AA8E-AB2AF958E1FAQ36409664-28977168-774F-401B-B8D3-7D8CC937B81FQ36589155-610B866C-2A96-404C-8B41-A4F28250D031Q36724810-8FEE2478-7489-48FE-9759-D19A443A2F57Q36887700-86524916-6AA2-4CC4-BA36-EEBB6FFD1426Q36914091-20FB2A93-96EE-4D77-82DC-72E889C7F758Q37109190-8DBF38D0-88F5-4400-8DFA-0EBB5C304645Q37215179-665E506A-4734-4499-B11F-AA43134D29E8Q37226494-2812E14B-9AD9-4525-9786-A0E81037CBB6Q37622957-066E0FE6-B2F8-4F41-A991-62176BBC1F01Q37694587-49725F88-CD16-4CCA-AB42-8D498843ABA1Q37731703-499360E3-F946-40CC-9541-22A5B8EF88B1Q37797467-F704445F-B698-4AAF-B410-FBD52523076FQ37817621-95069AD8-49E4-4AFB-86D0-EF0663221D6CQ37824712-93A978A5-3672-42F4-9843-6E3B89F7C1ABQ37858877-4051D122-BC8F-4F25-9EFC-90D7EBCFFB4AQ38018998-43C6FA28-09FA-48B1-8928-E440D4A0D153Q38062865-57EACF06-2A8C-40F0-9433-6318422C0CD0
P2860
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@ast
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@en
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@nl
type
label
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@ast
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@en
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@nl
prefLabel
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@ast
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@en
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@nl
P2093
P1433
P1476
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
@en
P2093
Dirk van den Boom
Lars Bullinger
Mathias Ehrich
Matthew R Nelson
Richard F Schlenk
P304
P356
10.1182/BLOOD-2009-03-211003
P407
P577
2009-11-10T00:00:00Z